Bpifrance Financement S.A. is a French financial institution that provides a wide range of financing solutions and support services for businesses at various stages of their development. Established in 1980 and based in Maisons-Alfort, France, the company offers medium to long-term loans, export insurance, real estate and equipment leasing, and working capital loans. Bpifrance also invests in startups, small and medium-sized enterprises (SMEs), and mid-cap companies through direct investments and fund management activities. Additionally, it provides consulting services for executives and training for CEOs, aiming to facilitate innovation and growth. Bpifrance was formed from the merger of several entities in July 2013, including OSEO, CDC Entreprises, and FSI, to enhance its role in supporting the financing of the French economy.
Director of Cross-Functional Investments Venture Capital
Elyssa Maufras du Châtellier
Investment Director
Charlotte Corbaz
Deputy Director of the Large Venture Fund and Deputy Managing Director
Sofia Dahoune
Associate
Vanessa Giraud
Managing Director
Laurent Higueret
Senior Investment Director, Healthcare and Life Sciences - Large Venture Fund
Hortense Jacon
Investment Associate
Veronique Jacq
Head of Digital Venture team
So-Yeon Koo
Senior Investment Manager
Eric Lefebvre
Director
Arnaud Legardeur
Investment Director
Serge Mesguich
Director
Louis Molis
Investment Director
Adrien Neel
Investment Director
Gilles Schang
Deputy Director
Tuan Tran
Investment Director / VC
938 past transactions
Topo.io
Pre Seed Round in 2023
Topo.io is a B2B SaaS company that develops digital salesrooms and customer collaboration platforms.
DataFret
Pre Seed Round in 2023
DataFret aids in the automation of goods invoicing processing. It is intended to improve relationships between shippers and carriers by making invoicing and management more fluid.
Kairos Discovery
Seed Round in 2023
Kairos Discovery is a biotechnology business that is exploring novel targeted cancer medicines. Their purpose is to create medicinal chemistry solutions that will transform patients' lives.
Goamigo
Pre Seed Round in 2023
Goamigo is a platform that enables influencers to design and market vacations to their networks.
Saola
Venture Round in 2023
Saola is an eco-friendly footwear company that develops one-of-a-kind shoes out of recycled and bio-based materials. Saola shoes are made from recycled PET, algae bloom foam, natural cork and organic cotton.
Fari Analytics
Pre Seed Round in 2023
Fari Analytics democratises access to the possibilities of data analysis and AI. The company's solution is built on current, anonymised data, whether it originates from an ERP, CRM, or BI platform.
Expliseat combines innovation and manufacturing performance in the lightest aircraft seat in the world: the Titanium Seat. At just 4 kg, this seat reduces fuel consumption considerably, resulting in savings of up to $500,000 per plane per year. And with 10 patents, the Titanium Seat also provides passengers with greater comfort and 2 inches more room, thanks to its unique ergonomic design.
ACSES
Venture Round in 2023
Acses is a startup with the common purpose of assisting businesses in simplifying and optimizing their customer journey. It specializes in access control, using a system of connected smart lockers, and is powered by SaaS software.
Santé Académie
Series A in 2023
As a result of a lack of caregivers across the country, their tasks are evolving - doctors can be asked to practice a gynaecologist act, or a nurse to follow up on a patient under anticancer treatment. Meanwhile, medical knowledge is increasing all around the world - we estimate that 50% of it becomes useless after 7 years. Therefore how can we provide continuous training to 2 million caregivers? Santé Académie rethinks Continuing Medical Education by offering educational videos with cinematographic quality accessible by web or mobile. Each course is divided into 5 to 15 min episodes to adequate caregivers' schedules. Doctors, pharmacists, nurses, care assistants, and chiefs nurses, can access a catalogue of high-quality courses on clinical and regulatory themes customized to their daily practice. These courses are certified by the ANDPC and produced by the best experts from prestigious institutions. Our goal? To educate health professionals as well as their engagement, with the top-end knowledge directly accessible from their phone, to improve patient care from prevention to follow-up. A new experience already approved by more than 20 000 professional and health institutions (GHU Paris psychiatrie & neurosciences, Service de Santé des Armées …) !
Ynsect is a biotech company based in Evry, France, founded in 2011. It specializes in the production and processing of insects for use as sustainable feed in aquaculture and poultry farming. The company utilizes innovative vertical farming techniques to convert organic resources into high-quality insect-based nutrients, including proteins and lipids, which are essential for animal nutrition. In addition to feed applications, Ynsect processes insects into non-food products such as organic fertilizers and bioenergy. By automating its production processes and focusing on large-scale insect farming, Ynsect aims to provide premium organic alternatives that support the agricultural and environmental sectors. Its expertise has made it a valuable partner for agri-food professionals, laboratories, investors, and insect industry farmers.
Alentis Therapeutics AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland, focused on developing novel treatments for advanced liver diseases. Founded in 2019, the company aims to address conditions such as liver fibrosis, cirrhosis, and liver cancer, particularly targeting Claudin-1 positive tumors and organ fibrosis. Alentis employs a research platform that utilizes clinically relevant readouts and single-cell RNA sequencing of patient liver tissues, enabling the development of effective therapies to combat fibrosis and reverse the progression of these diseases. Through its innovative approach, Alentis Therapeutics seeks to improve outcomes for patients suffering from severe liver-related health issues.
Odimma is a biotech company specializing in precision medicine aimed at developing personalized cancer immunotherapy solutions. The company has created an innovative immunotherapy drug that harnesses a unique platform, integrating three specific immune components designed to work together with the patient's immune system. When administered, this approach aims to induce and enhance immune responses, providing patients with the potential to eliminate tumors while minimizing adverse side effects. Through its focus on personalized treatment strategies, Odimma seeks to improve outcomes for cancer patients by tailoring therapies to individual needs.
Hemerion
Seed Round in 2023
Hemerion is focused on creating innovative cancer treatments. The focus is on cutting-edge methods to treat glioblastoma, the most prevalent and dangerous primary brain tumour.
EyeLights SAS is a company based in Labege, France, specializing in the design and manufacture of GPS-enabled motorcycle helmets. Founded in 2016, EyeLights offers a unique head-up display system that projects critical information, such as GPS directions, hazard warnings, and traffic alerts, directly into the rider's field of vision. This innovative accessory enhances safety by allowing motorcyclists to keep their eyes on the road while accessing navigational and audio functions. The product is designed for easy installation on various helmet types and features compact optical technology that enables visibility over two meters. Its battery supports more than eight hours of use and is resistant to environmental factors such as rain and fog. By integrating with smartphones via Bluetooth, EyeLights aims to create a safer riding experience while ensuring that riders remain connected and informed.
Operator of a digital medicine company intended to provide insights on laboratory test results that are understandable to patients. The company fosters the interactions between laboratories, health professionals and patients and goes beyond results in patient care through the use of new technologies and artificial intelligence, enabling medical professionals to easily interpret and diagnose in a personalized and effective way.
Palm
Seed Round in 2023
PALM is a cutting-edge company that leverages the power of AI and deep learning to provide enterprises with a comprehensive solution for talent management, development, and upskilling. We understand the evolving nature of work and the importance of growing a diverse global workforce. PALM empowers organizations to harness the full potential of HR data analytics and transform it into actionable insights in real-time, enabling a winning talent strategy. Our Offering: PALM offers a talent marketplace and collaborative platform that streamlines talent development, retention, and upskilling processes. With PALM, enterprises can effortlessly manage their workforce, identify emerging skills, and bridge the skills gap using AI-driven automation. Our solution enables teams to connect with the right profiles and foster collaboration at all levels, ensuring optimal performance and skill enhancement. Key Features: Skills Mapping: PALM's advanced AI algorithms automatically map skills, providing organizations with a comprehensive understanding of their talent pool. This enables them to identify skill gaps and make informed decisions for training and development initiatives. Real-time Skills Gap Visualization: PALM allows organizations to visualize the skills gap in real-time, providing actionable insights for strategic decision-making. By knowing which skills are lacking, companies can prioritize training efforts and allocate resources effectively. Personalized Reskilling and Upskilling Programs: In today's rapidly changing work environment, PALM enables organizations to deliver personalized reskilling and upskilling programs at a global scale. This ensures that employees stay relevant and equipped with the latest skills required for their roles. Data-driven Talent Insights: PALM leverages AI and deep learning to transform HR data into actionable insights. Organizations gain a comprehensive overview of their talent ecosystem, enabling them to make informed decisions about talent acquisition, development, and retention strategies. Connectivity and Collaboration: PALM facilitates seamless connections with various stakeholders in a company's ecosystem, including permanent, temporary, and part-time employees, former employees, and independent experts. This fosters collaboration, knowledge sharing, and the creation of a vibrant talent network. Advantages: Future-ready Talent Strategy: PALM equips organizations to adapt to the ongoing revolution of work. By addressing skills obsolescence, project-based work, and increasing competition for talent, PALM ensures that companies are well-prepared for the future of work. Global Scale and Real-time Insights: PALM enables organizations to operate at a global scale by providing real-time, actionable insights. This empowers companies to make agile decisions and respond swiftly to talent-related challenges and opportunities. Enhanced HR Data Analytics: PALM unlocks the full potential of HR data analytics by integrating AI and deep learning capabilities. This results in richer and more accurate talent insights, driving strategic decision-making and improving overall performance. Improved Employee Retention: PALM helps organizations understand their talent better and repurpose employees for suitable roles, reducing turnover rates. By offering personalized development opportunities and nurturing a collaborative work environment, PALM supports employee satisfaction and retention. PALM has successfully raised €2 million in a recent funding round, attracting investments from prominent investors and business angels. Key investors include Kima Ventures, STATION F, the 212 founders program by CDG Invest, and bpifrance, with participation from notable business angels. Recognized for its innovation and potential, Palm has been honored as a member of the Future 40, an esteemed group that recognizes the 40 most promising startups among the 1,000 hosted on the STATION F campus.
Exotrail develops electric propulsion solutions for small satellites. Their safe and efficient Hall Effect Thrusters are helping build agile constellations to revolutionize telecommunication, earth observation, space, and science. David Henri, Jean-Luc Maria, Paul Lascombes, and Nicolas Heitz co-founded the company in Palaiseau, Ile-de-France in 2015.
Dianosic SAS is a healthcare organization based in Strasbourg, France, founded in 2017. The company specializes in developing innovative medical devices for Ear, Nose, and Throat (ENT) conditions. Its flagship product, the CAVI-T, is an asymmetrical intranasal balloon designed to manage spontaneous or postoperative bleeding through low-pressure compression, tailored to the unique anatomy of the nasal cavity. This device also features an active balloon that minimizes biofilm formation, targets specific bacteria, and promotes healing. Additionally, Dianosic is developing an Active Resorbable Intranasal Scaffold device aimed at treating chronic sinusitis in patients who do not respond to conventional drug therapies. These advancements enable healthcare professionals to monitor patients remotely, enhancing post-operative care and overall treatment efficacy.
Developer of a web application designed to offset carbon footprint through a monthly plan. The company's application estimates carbon impact in just a few clicks by calculating impactful expenses, enabling clients to understand and reduce their carbon impact and act against climate change.
Garantme is a French company established in 2017, based in Saint-Ouen, that specializes in providing rental guarantees for housing. The firm acts as a broker in insurance and banking services, offering solutions that enable tenants, particularly international students, to secure leases without the need for a guarantor. Garantme's services include assisting clients in compiling necessary documentation and providing landlords with rental income protection through solvency and partner insurance. Additionally, the company operates a platform called Garantme Search, which aids clients in finding suitable accommodation. By simplifying legal processes related to unpaid debts and offering rental deposits, Garantme ensures peace of mind for both tenants and property owners.
Atawey SAS, founded in 2012 and based in Le Bourget-du-Lac, France, specializes in designing and manufacturing autonomous energy solutions tailored for isolated sites. The company offers a comprehensive system that includes both short-term battery storage for daily needs and long-term hydrogen storage for annual energy requirements, ensuring total electrical autonomy even in challenging weather conditions. Atawey’s products cater to various applications, including isolated industrial sites, tropical and temperate housing, and locations with seasonal energy demands. By utilizing established French technologies, Atawey not only provides reliable and sustainable energy solutions but also emphasizes project management and adaptability to meet specific user needs. The company's commitment to environmental responsibility further enhances its appeal, positioning it as a leader in the provision of clean and efficient energy supply systems.
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.
WeLinQ is a quantum computing solution interconnecting processors.
Butterfly Job
Pre Seed Round in 2023
Butterfly Job is an innovative SaaS-based recruitment platform that aims to guide candidates towards their dream job. At Butterfly Job, we are determined to revolutionize recruitment for both candidates and companies. That's why we have developed cutting-edge technology to provide a personalized and innovative recruitment experience through our Adaptive Intelligence Matching Engine (AMIE) application. With AMIE, you will have a unique recruitment experience. Built on neural network algorithms and social psychology research, AMIE learns from each user interaction to continuously refine its relevance month after month. This constantly evolving technology adapts to the changing expectations of candidates and companies, offering you a personalized and innovative recruitment experience. Don't wait any longer to join the recruitment revolution and take advantage of the benefits of our constantly improving application.
Mycophyto is a French company founded in 2016, co-created by microbiologist Justine Lipuma and Senior Research Engineer Christine Poncet-Doise. Based in Mougins, the company focuses on developing biological solutions aimed at revitalizing soil and enhancing plant growth. Mycophyto specializes in analyzing soil to identify indigenous fungi and pathogens beneficial for plant development. By isolating, multiplying, and inoculating mycorrhizae, the company provides customized products and support services for new agricultural systems. This innovative approach allows plant researchers to cultivate crops and herbs using natural soil microorganisms, minimizing reliance on chemical fertilizers and promoting sustainable agricultural practices.
Odaptos designs and markets a SaaS product to perform usability testing in videoconferencing, analyze human emotions, and provide results and insights to understand the end-users. It is an artificial intelligence platform that allows users to perform usability testing.
Lisy.co operates an intelligent mailbox platform tailored for the food industry, facilitating centralized order management for producers, suppliers, and buyers. The platform simplifies the daily business operations of its users by automating administrative tasks associated with order management. It offers features such as auto-generated purchase orders and deliveries, automatic invoicing, inventory tracking, and catalog sharing. By promoting the development of short circuits for trade players, Lisy.co enhances efficiency and connectivity among stakeholders in the food sector.
45-8 Energy SAS is a company based in Metz, France, focused on the exploration and production of helium. Founded in 2017, it specializes in eco-friendly helium extraction and operates various helium exploration projects. The company also provides oil and gas consulting services, aiming to support businesses in accessing local helium supplies. By conducting subsurface exploration and research, 45-8 Energy seeks to develop a sustainable helium supply chain in the European market, which may help reduce the environmental impact associated with traditional helium sourcing.
Valneva SE is a specialty vaccine company dedicated to the development and commercialization of vaccines for infectious diseases that lack adequate solutions. The company offers two commercial vaccines for travelers: IXIARO/JESPECT, which protects against Japanese encephalitis, and DUKORAL, aimed at preventing cholera and certain types of diarrhea. Valneva is also advancing several vaccine candidates, including the only developmental vaccine for Lyme disease and a single-shot vaccine for chikungunya. Founded in 1999, Valneva operates in multiple countries, including Austria, Canada, France, Sweden, the United Kingdom, and the United States. The company is involved in a collaboration with Dynavax Technologies Corporation to further vaccine development for COVID-19. Valneva's focus is on addressing urgent public health needs through innovative vaccine solutions.
Kumulus Water is a company focused on producing drinking water using solar energy and atmospheric humidity. By mimicking the natural dew formation process, Kumulus has developed machines that autonomously generate potable water. These systems are equipped with advanced technologies such as embedded systems and predictive algorithms, allowing for remote monitoring and control from anywhere in the world. This innovative approach provides decentralized access to clean drinking water for various users, including families, industries, and hotels, ensuring a sustainable and cost-effective solution for water needs.
Guerbet is a healthcare company specializing in medical imaging, with a focus on manufacturing and marketing contrast agents for diagnostic purposes. With nearly 90 years of experience, it is the only pharmaceutical group dedicated solely to medical imaging globally, operating in almost 80 countries through subsidiaries and distributors. Guerbet's product portfolio includes a comprehensive range of contrast agents for various imaging modalities, such as X-ray, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and nuclear medicine. The company also offers injectors and related medical devices designed to enhance patient diagnosis and prognosis. Its well-known brands include Xenetix, Optiray, Dotarem, and others, all aimed at improving the quality of life for patients.
ChapsVision specializes in providing a data analysis platform that addresses complex business challenges for sectors with significant data footprints, such as Retail, Finance, and Public Services. The company offers a comprehensive suite of business solutions that are fully integrated around a unified Customer and Product repository. This modern analytical infrastructure equips clients with intelligence, investigation, and analysis tools that consolidate data from various sources into a single workspace. By doing so, ChapsVision supports its customers in effectively navigating and optimizing their digital transformation processes.
Devialet SAS is an audio technology company based in Paris, France, founded in 2007. It specializes in hybrid amplification technology that combines analog and digital elements to enhance audio devices. The company offers a range of products, including wireless earbuds, speakers, and amplifiers, as well as solutions for vinyl playback. Devialet aims to make its audio technology universally accessible and has developed products such as the Gemini wireless earbuds. Its offerings are available for purchase online and through various dealers and retail locations both in France and internationally.
Apmonia Therapeutics is focused on developing next-generation peptide-based therapies aimed at improving treatment options for various types of cancer, including glioblastoma, ovarian, colorectal, and pancreatic cancers. The company concentrates on targeting the tumor microenvironment, which plays a crucial role in cancer progression. By creating innovative drugs, Apmonia Therapeutics seeks to enhance therapeutic strategies for solid tumors and provide new perspectives in cancer treatment. Their approach includes the development of personalized immunotherapy solutions that utilize proprietary therapeutic peptides, ultimately aiming to improve the quality of life for patients battling cancer and assisting researchers in their efforts to advance cancer therapies.
ContentSquare is a digital experience insights optimization platform that helps businesses analyze customer behavior through vast amounts of anonymous web, mobile, and app interactions, adhering to data privacy regulations such as the EU GDPR and California CCPA. By integrating diverse data sets, including content, user experience, product offerings, pricing, acquisition channels, and technical performance, the platform generates insights and AI-driven recommendations to enhance digital performance throughout the customer journey. Its solutions enable clients to better understand user interactions, measure content effectiveness, and clarify consumer intentions, ultimately leading to increased revenue and engagement while reducing operational costs. ContentSquare serves over 700 enterprise clients, including notable brands like American Express, Best Buy, and LVMH.
Operator of a biotechnology company intended to develop drugs targeting specifically a new class of proteins involved in the resolution of inflammation. The company develops treatments based on monoclonal antibodies by treating human mucosal inflammatory diseases by inhibiting a target that could be implied in the early inflammatory process and the recruitment of innate immunity cells, enabling healthcare providers to cure their patients.
Ludocare focuses on developing therapeutic robots that assist patients with chronic diseases and their families. The company's innovative devices are designed to complement traditional drug treatments by providing personalized support that enhances treatment efficiency. By empowering patients, especially children, Ludocare aims to improve therapeutic compliance both quantitatively and qualitatively. This approach facilitates better disease management and helps stabilize essential treatments, ultimately contributing to improved autonomy and quality of life for patients and their families.
Developer of an artificial intelligence-based fetal ultrasound software intended to analyze and diagnose congenital malformations. The company's software combines the patient's medical history, genetic and biological data, and ultrasound semiology to assist physicians on the path to the right diagnosis and assists sonographers during prenatal screening scans, enabling healthcare practitioners to receive crucial support in conducting fetal ultrasound and mothers to take care of themselves and their children.
Venture Orbital Systems designs and develops launchers for nanosatellite operators. The company offers Zephyr, which is a small launcher that launches satellites into low polar orbit. The company was incorporated 2019 and is based in Reims, France.
Flying Whales is a French company founded in 2012, headquartered in Suresnes. The company specializes in an innovative aeronautic program designed for the transportation of heavy and oversized loads, effectively connecting land-locked regions to the global economy. Its approach aims to provide efficient logistics solutions for challenging transport needs, enhancing accessibility and fostering economic growth in various sectors.
Operator of a regenerative medicine company intended to develop breast regeneration alternatives by 3D bioprinting. The company develops a bioprosthesis for breast reconstruction, enabling women to regain their self-confidence through natural products and get long-lasting and aesthetic results after the surgery.
Siteflow is a developer of cloud-based service management software tailored for complex industries such as nuclear, manufacturing, special works, and oil and gas. Established in 2017 and headquartered in Paris, France, the company offers Siteflow Builder, an application designed to streamline operations, ensure timely execution of tasks, track project status, and assess performance on work sites. The software facilitates collaboration among colleagues and standardizes business operations, addressing the unique challenges of regulated industries where traditional methods have remained unchanged for decades. By focusing on user-friendly interfaces and functionalities, Siteflow aims to enhance user acceptance and ease the digital transformation process. Additionally, the company supports organizations in redesigning their workflows to achieve operational excellence, helping professionals to focus on critical tasks while improving overall efficiency through real-time monitoring and automated reporting.
Osivax SAS is a clinical-stage biotechnology company based in Paris, France, founded in 2017. The company specializes in the development of innovative vaccines and immunotherapies aimed at addressing infectious diseases and enhancing immune responses. Its proprietary technology includes oligoDOM v1.0 and oligoDOM v2.0, which are designed to improve both B and T-cell immune responses by facilitating the uptake of antigens into dendritic cells. This results in more effective immune responses, including significant activation of CD8 T cells. Osivax's approach allows for the development of a universal vaccine targeting various infectious diseases, including influenza, malaria, and emerging coronavirus strains, while also showing potential applications in cancer treatment.
Leanspace is a developer of an integrated cloud platform tailored for public and private space organizations, aimed at streamlining space missions. The platform combines cloud technologies with space engineering concepts, offering a range of generic functions as services via APIs. This approach allows organizations to build their systems in-house while only developing the specific functionalities they require, thereby reducing both time and costs. By providing an innovative and collaborative framework, Leanspace enhances the agility of space organizations, enabling them to maintain control over their tools and improve their competitiveness in an increasingly complex industry.
Strapi Solutions SAS is the developer of Strapi, an open-source content management framework built on Node.js that enables developers to create and manage APIs efficiently. Founded in 2016 and based in Paris, France, Strapi offers a headless CMS that separates the backend from the frontend, allowing developers to choose their preferred tools and frameworks for application development. The platform supports various use cases, including blogs, brand websites, and product catalogs, while providing a powerful dashboard for API management. Additionally, Strapi offers consulting and training services to assist customers in optimizing their use of the platform. With a focus on flexibility and ease of use, Strapi serves a global clientele, empowering developers to build robust back-end solutions with minimal effort.
Leanspace is a developer of an integrated cloud platform tailored for public and private space organizations, aimed at streamlining space missions. The platform combines cloud technologies with space engineering concepts, offering a range of generic functions as services via APIs. This approach allows organizations to build their systems in-house while only developing the specific functionalities they require, thereby reducing both time and costs. By providing an innovative and collaborative framework, Leanspace enhances the agility of space organizations, enabling them to maintain control over their tools and improve their competitiveness in an increasingly complex industry.
Scintil Photonics SAS, founded in 2018 and based in Grenoble, France, specializes in the development of silicon photonic integrated circuits aimed at advancing high-speed optical communications and chip interconnections. The company offers a range of products, including multi-wavelength lasers, waveguides, wavelength filters, and photodetectors. By employing wafer-scale bonding techniques that combine Silicon and Indium Phosphide materials, Scintil Photonics creates fully integrated circuits that enhance performance and reliability while significantly lowering implementation costs. Their innovative approach allows for the monolithic integration of optical amplifiers and lasers on advanced silicon photonic circuits, making their solutions suitable for a variety of industrial applications.
DCbrain offers a solution designed to assist teams managing data centers in optimizing their operations. By utilizing graph models and machine learning, the company provides a comprehensive view of the systems within data centers, showcasing a dynamic map of various flows, including energy and chilled water. Additionally, DCbrain features expert dashboards that facilitate the exploitation and maintenance of complex industrial networks, encompassing sectors such as gas, water, electricity, and logistics. This approach aims to improve efficiency and streamline processes for data center operations.
DBV Technologies S.A. is a clinical-stage biopharmaceutical company based in Montrouge, France, dedicated to developing epicutaneous immunotherapy products aimed at treating food allergies. The company's lead candidate, Viaskin Peanut, has completed Phase III clinical trials for peanut allergies in children and adults. Additionally, DBV is developing Viaskin Milk, currently in Phase I/II trials for cow's milk protein allergy and related conditions, and Viaskin Egg, which is in pre-clinical stages for hen's egg allergy. The company also works on a booster vaccine for Bordetella pertussis and has earlier-stage research programs targeting respiratory syncytial virus, Crohn's disease, celiac disease, and type I diabetes. DBV Technologies collaborates with Nestlé Health Science to create MAG1C, a diagnostic patch test for non-IgE mediated cow's milk protein allergy in infants and toddlers. Founded in 2002, the company aims to provide safe and effective treatments for food allergies through its innovative Viaskin technology platform, which delivers biologically active compounds via the skin to activate the immune system.
Diabeloop SAS is a medical device company based in Grenoble, France, that specializes in developing an electronic artificial pancreas for individuals with Type 1 diabetes. Founded in 2015, the company's innovative system comprises a continuous glucose sensor that monitors blood sugar levels and a smartphone application that communicates with a connected insulin pump to administer the optimal insulin dosage automatically. This closed-loop system aims to minimize the risk of hypoglycemia and related complications, thereby improving the quality of life for patients. By integrating advanced technology and artificial intelligence, Diabeloop seeks to streamline diabetes management, reducing the mental burden on users and allowing them to lead more uninterrupted lives.
UnitySC is recognized worldwide as a key player in inspection and metrology, combining advanced technologies in automated optical inspection and 3D imaging with high depth of focus line scanning, temporal-mode interferometry, spectrometry, and phase shift analysis. This enables customers to deliver higher yields and achieve faster time to market. We provide standard and customized solutions adapted to specific industrial needs and constraints, enabling a new era in process control.
Vade Secure SASU specializes in email security software, providing protection against phishing, spear phishing, malware, and ransomware. The company's offerings include solutions such as Vade Secure for Office 365, Isltphishing threat detection for security operations centers, and enterprise cloud and gateway services. Vade Secure employs heuristic filtering to analyze incoming emails in real-time, effectively identifying and neutralizing threats, including zero-day attacks. Additionally, the company manages low-priority emails through its Graymail Management feature, which organizes non-essential communications into a separate folder. Founded in 2008 and headquartered in Hem, France, Vade Secure serves a diverse range of sectors including international shipping, original equipment manufacturers, hosting companies, and enterprises. With a presence in five countries—USA, Canada, France, Hong Kong, and Japan—Vade Secure supports over 500 million mailboxes in 76 countries, ensuring round-the-clock assistance for its clients.
Club Employes is a web platform that provides a range of products and services at discounted prices specifically for employees of French companies. The platform is designed to enhance corporate culture by offering various employee benefits, including ticketing, subsidies, reimbursements, multi-brand e-gift vouchers, and business gifts. This service caters to both startups and multinational corporations, enabling them to support their teams and promote employee well-being effectively.
MatchTune is a music technology company that specializes in AI-driven music composition for video content. Founded in 2017 and headquartered in Paris, France, with an office in Las Vegas, the company provides a platform that generates original, royalty-free music tailored to the specific length and rhythm of a video in mere seconds. Its Augmented Composer tool allows users to create synchronized soundtracks quickly, addressing the increasing demand for high-quality music in the rapidly evolving video production landscape. Additionally, MatchTune features an innovative catalog search technology that enhances the efficiency of video editors by streamlining the music selection process.
Sencrop is an ag-tech startup that offers an in-field data-based platform to empower farmers to make better decisions in their daily agricultural activities. Sencrop designs and sells connected weather forecast solutions for farmers to measure rain, hygrometry, and wind speed. The sensors are cheap, robust, movable, and easy to use, making more efficient and sustainable farming possible
Arianee SA, founded in 2018 and based in Paris, France, specializes in providing digital certifications for products using blockchain technology. The company has developed an Ethereum-compatible platform that enhances the authentication process for branded products through a universal open-source protocol. This platform records all aspects of product creation and sales in an immutable ledger, ensuring that the information cannot be altered, deleted, or shut down. By facilitating a secure and reliable method for brands, owners, and third-party retailers to manage asset ownership and transfers, Arianee is establishing a global standard for the digital certification of valuable objects.
Implicity is a developer of a remote monitoring platform that enables the smart monitoring of patients with connected pacemakers and defibrillators. The platform utilizes artificial intelligence to sort and summarize patient data, assessing the criticality of alerts based on each patient's medical context. This innovative approach allows cardiologists and healthcare professionals to automate the remote monitoring process, consolidating patients' telepulse information into a single platform. By enhancing the efficiency of monitoring, Implicity aims to support hospital teams in delivering optimal quality care to their patients.
Handivoyage SAS operates an online travel booking platform specifically designed for individuals with disabilities. Founded in 2016 and based in Lyon, France, the company offers a variety of services, including holiday and hotel bookings, as well as access to medical equipment, medical aid, and adapted transportation. Committed to continuous improvement, Handivoyage actively collects customer feedback through comprehensive questionnaires following each stay, allowing them to enhance their service quality. This focus on user experience is central to their mission of providing accessible travel options for people with disabilities.
Xkey builds pure SaaS technology for digital asset security. We provide safe, cloud-native custody as a service that helps financial institutions—from startups to Tier-1 banks—transition to digital assets. It's a plug-and-play API allowing to add new assets to a portfolio and scale safely on a TSS-based institution-grade security infrastructure. Instead of using expensive, high maintenance, monolithic systems, we give access to a platform that gives our clients the freedom to release new products in days, while lowering total cost of ownership. Best-in-class, cryptographic security powered by a network of world-known Tier-1 custody banks. Plug-and-play, composable service flexibility. Continuous delivery, fast to deploy and integrate. Open API, fully-documented self-service environment. Asset agnostic support. ISO certified & compliant. Non-binding, transparent pricing. Global, agile and built for speed.
Phagos Biotech is a biotechnology company focused on combating antibiotic resistance through innovative bacteriophage solutions. The company develops customizable treatments designed to replace traditional antibiotics in animal farming, specifically targeting bacterial infections in seafood and livestock. By utilizing bacteriophages, which are natural predators of bacteria, Phagos aims to provide an efficient and sustainable alternative for health professionals dealing with incurable and life-threatening infections. This approach addresses the urgent need for effective treatments in the face of rising antibiotic resistance, contributing to safer agricultural practices and improved animal health.
Developer of a plant-based food technology designed to reduce meat consumption. The company's technology offers plant-based whole-cuts that contain plant proteins, enabling consumers to have alternatives that mimic the taste, texture, and smell of meat.
LimFlow is a developer of innovative peripheral endovascular technology aimed at treating end-stage chronic limb ischemia (CLI) patients. The LimFlow System uses a novel, ultrasound-guided percutaneous procedure to divert blood around diseased arteries into the tibial vein, effectively supplying oxygenated blood to the ischemic foot. This approach offers new hope to patients who have exhausted other revascularization options. By restoring blood flow, the system alleviates ischemic pain, promotes wound healing, reduces the risk of amputations, and helps restore mobility. Currently, the LimFlow System is approved for sale in markets regulated by the CE Mark, while in the United States, it remains an investigational device limited to research use.
Developer of a plant-based food technology designed to reduce meat consumption. The company's technology offers plant-based whole-cuts that contain plant proteins, enabling consumers to have alternatives that mimic the taste, texture, and smell of meat.
Guard Medical is the developer of NPseal™. We are an innovation driven company focused on creating easy-to-use and cost-effective solutions that enable prophylactic NPWT wound care of closed surgical incisions.
Priothera Ltd is a clinical-stage company focused on developing orally administered sphingosine 1 phosphate (S1P) receptor modulators aimed at treating haematological malignancies. Founded in 2020 and based in Dublin, Ireland, with an additional location in Saint Louis, France, the company seeks to improve patient outcomes by enhancing the curative potential of allogeneic hematopoietic stem cell transplantation. Its lead product, mocravimod, is designed to reduce the egress of specific T cell subsets from lymphatic tissues, thereby providing dual inhibition of graft versus host disease while promoting graft versus leukemia effects. Through this innovative approach, Priothera aims to deliver significant advancements in the treatment of patients with blood cancers.
Istya is a company focused on developing solutions for monitoring, predicting, and managing indoor air quality. Founded in 2021 and headquartered in Ile-de-France, France, Istya offers air quality sensors that measure fine particles and provide real-time monitoring and predictive analysis tailored to specific indoor environments. Their eco-designed solutions aim to enhance air quality while also reducing the energy costs associated with ventilation systems. Additionally, Istya's technology helps mitigate the risk of virus transmission through the air, promoting a healthier indoor atmosphere for various settings.
Developer of a pacing device designed to maintain cardiac rhythm. The company's implanted leadless pacemakers incorporate a self-sustaining power patented technology harvesting the heart's kinetic energy and bringing disruptive technologies to conventional leadless pacemakers, enabling patients and healthcare professionals with cost-effective alternatives that will revolutionize patients' quality of life.
Deepki SAS, founded in 2014 by Vincent Bryant and Emmanuel Blanchet, is a Paris-based company specializing in data analysis for energy efficiency. The firm focuses on identifying energy savings across numerous buildings simultaneously. By leveraging advanced data analytics, Deepki aims to optimize energy consumption and promote sustainable practices in the built environment.
Operator of a clothing platform intended to offer sportswear from recycled material. The company's platform offers various types of clothes like t-shirts, pants, shorts, leggings, and many more that are made from Tencel which is non-toxic and ecological, enabling people to get comfortable activewear at an affordable price while helping the environment.
Invivox is an innovative online platform that connects medical professionals for practical, in situ training sessions, primarily in small groups or one-on-one settings. By facilitating these interactions among doctors worldwide, Invivox aims to enhance medical education and ultimately improve patient care. The platform not only offers interactive online classes but also publishes weekly medical magazines and curates specialized training opportunities in collaboration with a network of international experts. Through these initiatives, Invivox democratizes access to knowledge in the healthcare sector, providing valuable mentorship across various medical specialties.
Kayrros is a Paris-based company specializing in advanced data analytics for the global energy market. Founded in 2016, it provides valuable insights by integrating unstructured data, such as satellite imagery and social media, with traditional financial and technical data. Employing over 100 professionals from diverse backgrounds, Kayrros operates not only in Paris but also has offices in Houston, London, New York, and Singapore. The company focuses on delivering near real-time information that enhances investment decisions and promotes transparency in energy markets. Kayrros also addresses environmental concerns by offering a platform that helps assess climate impact and energy-transition risks, enabling governments, corporations, and investors to make informed decisions regarding their environmental strategies.
Vaxxel is a biotechnology company focused on developing innovative live-attenuated vaccines targeting critical respiratory diseases, specifically bronchiolitis and pneumonia caused by pneumoviruses. The company specializes in creating novel vaccine candidates aimed at treating infections associated with human metapneumovirus and the human respiratory virus. By leveraging its proprietary platform, Vaxxel aims to provide effective solutions for healthcare providers to combat these significant health challenges.
Konect is a software-as-a-service (SaaS) platform designed to serve the gaming community by enabling users to create personalized websites. The platform allows gaming enthusiasts to build their online profiles, connect with other gamers, and discover opportunities. Users can centralize all their online content, making it easy to share with their community. This streamlined approach not only fosters connections among gamers but also simplifies the process of sharing content and engaging with a wider audience.
Brenus Pharma is focused on developing cell-based immunotherapies aimed at treating solid tumors. The company utilizes an allogeneic platform to create anti-cancer cell vaccines, which leverage the patient's immune system to combat cancer and reduce the risk of treatment resistance. Their approach emphasizes generating multiple candidate therapies efficiently, allowing for cost-effective scaling and integration with existing treatment standards. With a strong intellectual property portfolio and a team of experienced professionals, including renowned oncologists, Brenus Pharma seeks to educate the immune system to recognize and respond to tumor-associated and tumor-specific antigens, enhancing the effectiveness of chemotherapy and radiotherapy in cancer care.
Archeon is focused on creating innovative solutions for the monitoring, diagnosis, and treatment of critically ill patients in prehospital care. The company develops artificial intelligence-based technologies aimed at enhancing ventilation quality in emergency medical services. Its products are designed to be practical, user-friendly, and intuitive for emergency caregivers, providing real-time feedback on the quality of ventilation administered to patients. This approach aims to improve patient outcomes and support medical professionals in high-pressure situations.
Doctolib is an online booking platform and management software provider based in Paris, France, that serves the healthcare sector across Europe. Established in 2013, the platform connects patients with healthcare practitioners, facilitating the scheduling of appointments with ease. With 25 million monthly visitors, it supports 65,000 health practitioners in over 1,300 facilities, offering a comprehensive service that enhances appointment management, reduces no-show rates, and attracts new patients. For patients, Doctolib provides a free service that allows them to find nearby doctors or dentists and book appointments 24/7 in just a few clicks. The platform aims to streamline access to healthcare services for both practitioners and patients, improving overall efficiency in the healthcare system.
Alice & Bob is a Paris-based company founded in 2020 that specializes in the manufacture of universal, error-free quantum computers. The company's innovative technology features self-correcting superconducting quantum bits, which allow for fault-tolerant quantum computing. This capability enables the execution of any quantum algorithm, thereby assisting industries and researchers in addressing complex challenges across various fields. By focusing on developing advanced quantum computing solutions, Alice & Bob aims to facilitate breakthroughs in solving significant problems in quantum research and industry applications.
Flowlity SAS is a Paris-based company that specializes in supply chain management through its artificial intelligence-driven software as a service (SaaS) platform. Founded in 2018, Flowlity's platform facilitates synchronization planning among manufacturers, suppliers, and customers by collecting and analyzing data from all parties involved. This enables Flowlity to provide recommendations on optimal ordering, production, and inventory levels, effectively reducing shortages and excess stock. The platform integrates with existing IT systems and offers real-time inventory analysis and cost optimization strategies, ensuring companies can visualize their order status and planning more effectively. Flowlity is supported by prominent organizations such as Entrepreneur First, Agoranov, and Station F.
Tenacy is a developer of cloud-based risk assessment and management software focused on enhancing cybersecurity processes across various organizational contexts. The platform enables businesses to assess and define risks, manage incidents and deviations, and create dashboards for performance measurement. It also offers benchmarking data and decision support tools, allowing organizations to integrate precise and customized cybersecurity governance. By providing a collaborative environment, Tenacy helps companies protect their assets and improve operational efficiency in managing cybersecurity challenges.
Kyotherm SAS is an investment company based in Paris, France, that focuses on financing renewable heating and energy efficiency projects. Established in 2011, it provides project equity to support the development of energy infrastructure and acquires stakes in various renewable energy production initiatives, including geothermal and biomass heating plants, as well as district heating networks. Kyotherm collaborates with a range of stakeholders, including energy service providers, engineering firms, developers, heat consumers, and equipment manufacturers, to facilitate third-party financing for these projects.
LISAqua operates a sustainable aquaculture farm focused on breeding prawns using an innovative process that avoids antibiotics and pollution. The company's farming methodology incorporates advanced predictive modeling technology to monitor and anticipate changes in pond water conditions. By employing the perm aquaculture method, which integrates complementary species to create a closed marine ecosystem, LISAqua aims to provide responsibly sourced seafood to consumers and communities. This approach not only enhances environmental sustainability but also promotes healthy seafood production.
Susu is a health tech company focused on providing accessible and affordable healthcare services to families in the African diaspora. The company offers a comprehensive range of services, including preventive care, medical treatments, chronic disease management, and authentic medications. By delivering health bundle services through its platform, Susu aims to facilitate long-term health support for patients, ensuring effective monitoring of various health conditions such as pregnancy and chronic diseases. This approach enables individuals to access quality healthcare services and insurance, promoting overall well-being within the communities it serves.
Kubo Labs is a developer of a cloud-based platform designed to address and resolve issues within Kubernetes clusters. The platform conducts various real-life scenario simulations to identify potential misconfigurations and bad practices that can lead to security incidents or performance problems. By leveraging best practices embedded in its suite of products, Kubo Labs helps organizations detect and resolve security and operational issues in real time. This proactive approach aims to mitigate the risks associated with Kubernetes adoption, ensuring that businesses can manage their cloud environments more effectively while avoiding the rising costs often associated with Kubernetes-related challenges.
Susu is a health tech company focused on providing accessible and affordable healthcare services to families in the African diaspora. The company offers a comprehensive range of services, including preventive care, medical treatments, chronic disease management, and authentic medications. By delivering health bundle services through its platform, Susu aims to facilitate long-term health support for patients, ensuring effective monitoring of various health conditions such as pregnancy and chronic diseases. This approach enables individuals to access quality healthcare services and insurance, promoting overall well-being within the communities it serves.
CarbonWorks specializes in the development of algae photobioreactors that utilize microalgae to capture and convert carbon dioxide. The company's technology industrializes microalgal photosynthesis, enabling the transformation of carbon emissions from various manufacturers into biomass. This biomass can be used in agricultural biocontrol products, as well as in human and animal food markets. By focusing on the large-scale production of safe bioproducts, CarbonWorks aims to help industries reduce their carbon footprints and promote sustainability.
Cell-Easy SAS operates as a stem cell contract development and manufacturing organization (CDMO) that provides ready-to-inject adipose derived allogeneic stem cells for preclinical and clinical development projects. The company’s allogeneic production process allows using the biological material of a healthy donor to help thousands of patients. The company was incorporated in 2017 and is based in Toulouse, France.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.